Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSirius Real Estate Regulatory News (SRE)

Share Price Information for Sirius Real Estate (SRE)

Share Price is delayed by 15 minutes
Get Live Data
96.85    0.15 (0.16%)
Bid:
96.75
Ask:
96.85
Spread: 0.10 (0.103%)
Market Cap: £1.53b
SRE Live PriceLast checked at - London Stock Exchange

Intraday Sirius Real Estate Share Chart

Director/PDMR Shareholding

5 Aug 2024 15:00

RNS Number : 2292Z
Sirius Real Estate Limited
05 August 2024
 

SIRIUS REAL ESTATE LIMITED

(Incorporated in Guernsey)

Company Number: 46442

JSE Share Code: SRE

LSE (GBP) Share Code: SRE

LEI: 213800NURUF5W8QSK566

ISIN Code: GG00B1W3VF54

 

5 August 2024

Sirius Real Estate Limited

 

("Sirius Real Estate", "Sirius" or the "Company")

 

Notification of a transaction by a Person Discharging Managerial Responsibilities ("PDMR")

Notification and public disclosure of a transaction by a PDMR.

Notification of dealing form

1.

Details of PDMR

a)

Name

Andrew Coombs

2.

Reason for the notification

 

 

a)

Position / status

Chief Executive Officer

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer

a)

Name

Sirius Real Estate Limited

 

b)

LEI

213800NURUF5W8QSK566

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of no par value. 

b)

Identification code

GG00B1W3VF54

c)

Nature of the transaction

Purchase of shares into a self-invested pension.

 

Following this transaction, Mr. Coombs holds a beneficial interest in 11,785,023 shares, representing 0.7795% of the Company's issued share capital.

d)

Price(s) and

volume(s)

Price(s)

(p/GBP)

 

Volume(s)

Total(s)

(p/GBP)

0.960717

26,565

25,521.45

e)

Highest price, lowest price and volume weighted average price

High

 

Low

VWAP

N/A

N/A

N/A

f)

Date of the transaction

2 August 2024

g)

Place of the transaction

London Stock Exchange (XLON)

h)

Nature and extent of interest in the transaction

Direct, beneficial

i)

Clearance to deal in these securities was obtained in accordance with paragraph 3.66 of the JSE Listings Requirements. 

 

 

For further information:

 

Sirius Real Estate

Andrew Coombs, CEO

Chris Bowman CFO

 

 

 

+44 (0) 20 3059 0855

FTI Consulting (financial PR)

Richard Sunderland

James McEwan

Talia Shirion

SiriusRealEstate@fticonsulting.com

 

+44 (0)20 3727 1000

 

JSE Sponsor

PSG Capital

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFSFTVIEIIS
Date   Source Headline
2nd Apr 20209:30 amRNSTotal Voting Rights
1st Apr 20208:00 amRNSNotice of Trading Update
27th Mar 20203:50 pmRNSDealing In Securities By Employee Benefit Trust
26th Mar 202012:00 pmRNSDirector/PDMR Shareholding
25th Mar 20207:00 amRNSSirius Real Estate Covid-19 update
20th Mar 20202:15 pmRNSDirector/PDMR Shareholding
19th Mar 20204:41 pmRNSSecond Price Monitoring Extn
19th Mar 20204:36 pmRNSPrice Monitoring Extension
11th Mar 20203:25 pmRNSHolding(s) in Company
6th Mar 20201:20 pmRNSHolding(s) in Company
5th Mar 20207:00 amRNSSirius completes debut Schuldschein issuance
27th Jan 202012:10 pmRNSDirector/PDMR Shareholding
23rd Jan 20208:30 amRNSHolding(s) in Company
14th Jan 202012:15 pmRNSSecond scrip allotment
10th Jan 20202:00 pmRNSAllotment of Scrip Dividend
6th Jan 20207:00 amRNSSirius acquires two business parks for EUR33.4m
2nd Jan 20207:00 amRNSTotal Voting Rights
19th Dec 201911:00 amRNSInterim report posted to shareholders and NSM
19th Dec 201911:00 amRNSCash fraction applicable to the Scrip Dividend
17th Dec 20197:00 amRNSCompletion of acquisition
10th Dec 20193:20 pmRNSDirector/PDMR Shareholding
2nd Dec 20191:00 pmRNSScrip Dividend Announcement
2nd Dec 20197:00 amRNSSirius acquires office complex near Munich Airport
28th Nov 20199:30 amRNSHolding(s) in Company
25th Nov 20197:00 amRNSHalf-year Report
11th Nov 20197:30 amRNSHolding(s) in Company
6th Nov 20197:30 amRNSHolding(s) in Company
31st Oct 20193:15 pmRNSHolding(s) in Company
23rd Oct 20197:00 amRNSAppointment of Company Secretary
22nd Oct 201910:00 amRNSHolding(s) in Company
2nd Oct 20197:00 amRNSTrading Update and Extension of Banking Facility
1st Oct 20193:30 pmRNSTotal Voting Rights
13th Sep 20197:00 amRNSHolding(s) in Company
6th Sep 20194:20 pmRNSHolding(s) in Company
4th Sep 20194:00 pmRNSHolding(s) in Company
2nd Sep 20197:00 amRNSCompletes acquisition of 2nd Bochum property
28th Aug 20193:00 pmRNSDirector/PDMR Shareholding
27th Aug 20193:04 pmRNSDirector/PDMR Shareholding
22nd Aug 20194:15 pmRNSAdmission of Scrip Shares & Update re Scrip Circ.
14th Aug 201911:15 amRNSAllotment of Scrip Dividend
1st Aug 201911:45 amRNSSirius completes jv with AXA Investment Managers
29th Jul 20194:50 pmRNSResult of Annual General Meeting
26th Jul 20191:00 pmRNSSirius notarises two acquisitions
22nd Jul 20192:30 pmRNSHolding(s) in Company
11th Jul 20194:15 pmRNSHolding(s) in Company
11th Jul 20199:30 amRNSCash fraction applicable to the Scrip Dividend
8th Jul 20193:30 pmRNSHolding(s) in Company
8th Jul 20193:30 pmRNSHolding(s) in Company
5th Jul 20199:00 amRNSHolding(s) in Company
1st Jul 20197:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.